20 (AIDX) Total Debt (2025)
20 (AIDX) reported Total Debt of $143382.0 for Q4 2025.
20 (AIDX) Total Debt (2025) Analysis & Trends
20 has reported Total Debt for 1 years, with the latest figure at $143382.0 in Q4 2025.
- For the quarter ending Q4 2025, Total Debt changed N/A year-over-year to $143382.0; the trailing twelve-month figure through Dec 2025 stood at $143382.0 (changed N/A YoY), and the FY2025 full-year result was $143382.0, changed N/A from the prior year.
- Total Debt for Q4 2025 stood at $143382.0.
- The five-year high for Total Debt was $143382.0 in Q4 2025, with the low at $143382.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 34.05 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 14.72 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 28.07 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 11.03 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 598.50 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 10.13 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 9.48 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | - |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 1.93 Bn |
| 10 | 20 | - | - | 62,884.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 143,382.00 |